Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Acute Respiratory Failure-III

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension.

JAMA network open·2025

Same author

Ambiguous Clinical Presentations and Imaging Findings in Genetic Dilated Cardiomyopathy.

JACC. Case reports·2024

Same author

A Case of Reverse McConnell's Sign Associated With Acute Respiratory Distress Syndrome and Septic Shock.

Cureus·2024

Same author

Frequency of screening and SBT Technique Trial-North American Weaning Collaboration (FAST-NAWC): an update to the protocol and statistical analysis plan.

Trials·2023

Same author

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

JAMA·2022

Same author

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

JAMA·2020

Search research articles

Related Experiment Video

Updated: Apr 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Critically Ill Patients with Interstitial Lung Disease.

Ryan Hadley¹, Robert Hyzy¹

¹Division of Pulmonary & Critical Care Medicine, University of Michigan Health System, 1500 East Medical Center Drive, 3916 Taubman Center, SPC 5360, Ann Arbor, MI 48109, USA.

Clinics in Chest Medicine

|August 26, 2015

Summary

Interstitial lung disease (ILD) impairs respiratory function and can lead to critical illness. This review covers mechanical ventilation, exacerbations, and surgical issues for critically ill ILD patients.

Keywords:

Idiopathic pulmonary fibrosis Intensive care unit Interstitial lung disease

More Related Videos

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

Intravital Widefield Fluorescence Microscopy of Pulmonary Microcirculation in Experimental Acute Lung Injury Using a Vacuum-Stabilized Imaging System

Intravital Widefield Fluorescence Microscopy of Pulmonary Microcirculation in Experimental Acute Lung Injury Using a Vacuum-Stabilized Imaging System

Published on: April 6, 2022

Related Experiment Videos

Last Updated: Apr 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

Intravital Widefield Fluorescence Microscopy of Pulmonary Microcirculation in Experimental Acute Lung Injury Using a Vacuum-Stabilized Imaging System

Intravital Widefield Fluorescence Microscopy of Pulmonary Microcirculation in Experimental Acute Lung Injury Using a Vacuum-Stabilized Imaging System

Published on: April 6, 2022

Area of Science:

Pulmonology
Critical Care Medicine

Background:

Interstitial lung disease (ILD) is a diverse group of lung disorders impacting respiratory function.
Patients with ILD face risks of critical illness due to respiratory failure, organ failure, or surgery.

Purpose of the Study:

To provide guidance for intensivist management of critically ill patients with Interstitial Lung Disease.
To discuss key aspects of care including mechanical ventilation, exacerbations, and surgical considerations.

Main Methods:

Review of current literature and clinical practice guidelines.
Discussion of mechanical ventilation strategies (invasive and noninvasive).
Analysis of exacerbation syndromes and their management.
Consideration of perioperative care for ILD patients.

Main Results:

Mechanical ventilation requires careful consideration in ILD patients due to potential for barotrauma and ventilator-induced lung injury.
Noninvasive ventilation may be beneficial in select cases but carries risks.
Recognizing and managing acute exacerbations is crucial for patient outcomes.
Surgical patients with ILD require specialized perioperative management.

Conclusions:

Critically ill ILD patients present unique management challenges.
Optimal care involves tailored mechanical ventilation, prompt recognition of exacerbations, and careful surgical planning.
Intensivists must be prepared to manage these complex patients effectively.